The Cocktail Report (sounds really smart around your friends):
Researchers at USC Leonard Davis School of Gerontology analyzed data from 3,884 adults aged 70 and older in the US Health and Retirement Study, measuring seven domains of biological aging, including epigenetic clocks, inflammation, and transcriptomic aging.
Shingles-vaccinated adults showed significantly slower epigenetic aging, slower transcriptomic aging (changes in how genes are read and expressed), and a lower composite biological aging score compared to unvaccinated peers.
Inflammation scores were meaningfully lower in vaccinated individuals, supporting the hypothesis that the vaccine works partly by suppressing reactivation of the varicella-zoster virus, the same virus that causes chickenpox, which silently drives chronic inflammatory load as we age.
The biological aging benefits were most pronounced within three years of vaccination, but slower aging persisted well beyond that window in vaccinated individuals.
The study found no significant association between shingles vaccination and neurodegeneration or cardiovascular biomarkers, suggesting the benefits are specific to molecular and inflammatory aging processes.
Most people think of the shingles vaccine as protection against a painful rash. A study published in The Journals of Gerontology: Series A by USC researchers suggests it may be doing something more fundamental: slowing the biological aging process itself.
The research team, led by Jung Ki Kim and Eileen Crimmins at the USC Leonard Davis School of Gerontology, drew on data from nearly 4,000 Americans aged 70 and older. They measured biological age across seven dimensions including inflammation, epigenetic aging (chemical changes to DNA that predict mortality and physiological decline), transcriptomic aging, immune function, and cardiovascular markers.
After adjusting for demographics, health history, and other variables, shingles-vaccinated adults showed significantly slower epigenetic and transcriptomic aging and a lower overall composite biological aging score.
The inflammation finding may be the most mechanistically important. Varicella-zoster, the virus behind both chickenpox and shingles, goes dormant in nerve tissue after initial infection and periodically reactivates at low levels throughout life, quietly driving systemic inflammation.
By suppressing that reactivation, the vaccine may reduce a chronic inflammatory burden that accelerates molecular aging.
"By helping to reduce this background inflammation, possibly by preventing reactivation of the virus that causes shingles, the vaccine may play a role in supporting healthier aging," said Kim.
The timing findings add nuance. Epigenetic and transcriptomic improvements were strongest within three years of vaccination, while reductions in inflammation and innate immune aging became more significant after four or more years.
The benefits did not vanish after the three-year window; they shifted in character.
Worth noting: this study is observational and cross-sectional, meaning it cannot prove the vaccine causes slower aging, only that the two are associated. Longitudinal studies tracking the same individuals over time are needed to confirm the pattern.
Also worth noting: no significant associations were found for neurodegeneration or cardiovascular blood markers, so the findings should not be read as evidence that the shingles vaccine prevents dementia or heart disease.
Why Should You Care?
The shingles vaccine (Shingrix) is already recommended for all adults aged 50 and older by the CDC, and it is covered by most insurance plans. If you have not yet received it, this study adds a meaningful new reason beyond shingles prevention to have that conversation with your doctor.
For anyone tracking their biological age or working to reduce inflammaging (the chronic low-grade inflammation that drives age-related disease), a vaccine you can schedule this week may now belong on that list alongside diet, exercise, and sleep.
Sources:
1. Kim JK, Crimmins EM. "Association between shingles vaccination and slower biological aging: Evidence from a U.S. population-based cohort study." The Journals of Gerontology: Series A, January 20, 2026. https://doi.org/10.1093/gerona/glag008
2. USC Leonard Davis School of Gerontology press release (January 19, 2026): https://gero.usc.edu/2026/01/19/shingles-vaccine-slower-biological-aging/
